New device automates fluid removal to ease heart failure symptoms
NCT ID NCT06272734
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This pilot study tests the Reprieve System, a bedside device that automatically adjusts the delivery of a diuretic (furosemide) and saline based on the patient's real-time urine output. The goal is to safely and quickly remove excess fluid from 50 hospitalized adults with acute decompensated heart failure. The study focuses on whether the device works as intended without causing harm.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Reprieve System (a bedside device that automatically delivers the diuretic furosemide and saline based on real-time urine output)
What this could lead to
If successful, this device could offer a safer, more personalized way to remove excess fluid in heart failure patients, potentially reducing hospital stays and complications.
What could go wrong
This is a very early pilot study with only 50 participants, so results may not apply to all patients. The device could malfunction or cause side effects like dehydration or kidney issues.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE DECOMPENSATED HEART FAILURE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Tbilisi Heart and Vascular Clinic
RECRUITINGTbilisi, 0159, Georgia
Contact Phone: •••-•••-•••• Email: •••••@•••••